China Vanke Co.,Ltd.
000002
Cambricon
688256
Chongqing Sokon Industry Group Stock
601127
4
Contemporary Amperex Technology
300750
5
Foxconn Industrial Internet
601138
CN Stock MarketDetailed Quotes
600299 Bluestar Adisseo
- 11.72
- +0.02+0.17%
Market Closed Jan 22 15:00 CST
31.43BMarket Cap28.87P/E (TTM)
11.77High11.49Low70.94KlotVolume11.60Open11.70Pre Close82.60MTurnover0.27%Turnover Ratio616.84P/E (Static)2.68BShares12.8552wk High1.99P/B31.43BFloat Cap6.3952wk Low12.87Limit Up2.68BShs Float48.48Historical High10.53Limit Down2.39%Amplitude1.24Historical Low0.06Dividend TTM11.64Avg Price37.17KlotAsk0.51%Div YieldTTM100Lot Size31.78KlotBid
Bluestar Adisseo News
Bluestar Adisseo (600299): As a leading company in methionine, it is stable and poised for long-term success, backed by potential industrial synergy with Sinochem Group.
The company has undergone more than 80 years of development and has now become a leader in the methionine Industry, with a Global layout. The company is committed to continuously providing innovative products and services for the Fodder and food Industry, actively implementing the "dual pillar" Global Strategy, which focuses on continuously consolidating.
Bluestar Adisseo (600299): Advancing toward becoming a global leader in animal nutrition products, with promising growth in specialty products for the future.
The company has been deeply involved in the animal nutrition field for many years, firmly executing a "dual pillar" development Global Strategy characterized by leading methionine and accelerating the development of specialty products. The company is a Global leader in the production of animal nutrition additives, focusing on providing innovation and sustainability for the animal Fodder sector.
The pig industry is undergoing changes! "Cost reduction" has become the key to success or failure. Are publicly listed pig companies experiencing better-than-expected profit improvements?
Under the dual effect of rising Pork prices and falling costs, the profitability of listed pig farming companies is rapidly improving.
bluestar adisseo (600299) performance review for the third quarter of 2024: Strong sales of methionine, significant increase in performance quarter-on-quarter and year-on-year.
Event: On October 30, 2024, Bluestar Adisseo announced its third quarter report of 2024: the company achieved a revenue of 11.376 billion yuan in the first three quarters of 2024, an increase of 18.32% year-on-year; achieving a net income attributable to the parent of 1
Revenue Beat: Bluestar Adisseo Company Beat Analyst Estimates By 5.5%
Bluestar Adisseo Falls to Q3 Loss, Revenue Up 25%
Andisu 2024 Third Quarter Report
ANDISU Announces Key Operating Data for the Third Quarter of 2024
Bluestar Adisseo (600299.SH): The net income for the first three quarters is approximately 1.003 billion yuan.
Glorycrops reported on October 29th that Bluestar Adisseo (600299.SH) announced that its revenue in the first three quarters of 2024 was approximately 11.376 billion yuan, an increase of 18.32% year-on-year; net income attributable to shareholders of listed companies was approximately 1.003 billion yuan; basic earnings per share was 0.37 yuan.
Express News | Bluestar Adisseo: elected Hao Zhigang as the chairman.
Bluestar Adisseo (600299): Good growth of methionine, continuous capacity expansion to consolidate its leading position.
Bluestar Adisseo releases its 2024 interim report: in the first half of 2024, it achieved revenue of 7.261 billion yuan, YoY +14.74%, and net income attributable to the parent company of 0.608 billion yuan, YoY +1719.14%. The main product is eggs.
Bluestar Adisseo H1 Profit Surges 18-Fold; Shares Down 3%
Andisu 2024 Semi-Annual Report
Andisu 2024 Semi-Annual Report Summary
Bluestar Adisseo (600299.SH): net income in the first half of the year was 0.608 billion yuan, a year-on-year increase of 1719.14%.
Bluestar Adisseo (600299.SH) announced its semi-annual report for 2024, achieving a revenue of 7.261 billion yuan in the first half of the year, a year-on-year increase of 14.74%; achieving a net income attributable to shareholders of listed companies of 0.608 billion yuan, a year-on-year increase of 1,719.14%; achieving a net income attributable to shareholders of listed companies after deducting non-recurring gains and losses of 0.705 billion yuan, a year-on-year increase of 6,522.57%; basic earnings per share of 0.23 yuan. In the first half of 2024, the net income attributable to shareholders of listed companies and the net income attributable to shareholders of listed companies after deducting non-recurring gains and losses
Express News | Bluestar Adisseo: The net income attributable to shareholders in the first half of the year was 0.608 billion yuan, a year-on-year increase of 1719.14%.
Bluestar Adisseo (600299.SH): net income of 0.608 billion yuan in the first half of the year, a year-on-year increase of 1719.14%.
Bluestar Adisseo (600299.SH) announced its semi-annual report with a revenue of 7.26 billion yuan, a year-on-year growth of 14.74%, a net income of 0.608 billion yuan, a year-on-year growth of 1719.14%, a non-GAAP net income of 0.705 billion yuan, a year-on-year growth of 6,522.57%, and an EPS of 0.23 yuan.
Express News | Bluestar Adisseo: Net income in the first half of the year increased by 1719.14% year-on-year.
Express News | Sealand Securities: Vitamins' prosperity accelerates upward.
Express News | Delivery of some vitamin products from BASF has been affected by force majeure. Concept stocks have surged and over 10 listed companies have responded to their related business layout.